LLY compared with SNDX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

SNDXSyndax Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

SNDXSyndax Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

SNDX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.0%▲+9.08%×0.76

Q2 FY26±7.7%▲+4.40%×0.57

= impliedLLY realized, solidSNDX realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

Q1 FY26

±11.8%

▼−10.83%

×0.92

Feb 27 '26±10.1%▲+5.03%×0.50

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

SNDXSyndax Pharmaceuticals Inc

9.53▲+1.67%· post 9.79

ClosedNov 6 '26

Mkt cap$851.9MRevenue$83MQ3 FY26Revenue$172MFY25

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

SNDXSyndax Pharmaceuticals Inc

1,360.90▼−0.28%post 1,358.90

Price

9.53▲+1.67%post 9.79

$1.2T

Mkt cap

$851.9M

Q3 FY26$24.4B

Revenue

$83MQ3 FY26

FY25$65.2B

Revenue

$172MFY25

LLY1,360.90▼−0.28%vsSNDX9.53▲+1.67%ClosedNov 6 '26